Penumbra, Inc Finance Lease, Right-of-Use Asset, Amortization
Penumbra, Inc (PEN) reported Finance Lease, Right-of-Use Asset, Amortization of $3.58 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-02-25
- Penumbra, Inc finance lease, right-of-use asset, amortization for the quarter ending 2022-12-31 was $822.00K, a 2.88% increase year-over-year.
- Penumbra, Inc finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was $815.00K, a 5.03% increase year-over-year.
- Penumbra, Inc finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was $810.00K, a 6.58% increase year-over-year.
- Penumbra, Inc finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $805.00K, a 7.91% increase year-over-year.
- Penumbra, Inc finance lease, right-of-use asset, amortization for fiscal 2025 was $3.58M, a 1.19% increase from fiscal 2024.
- Penumbra, Inc finance lease, right-of-use asset, amortization for fiscal 2024 was $3.54M, a 5.64% increase from fiscal 2023.
- Penumbra, Inc finance lease, right-of-use asset, amortization for fiscal 2023 was $3.35M, a 2.98% increase from fiscal 2022.
- Penumbra, Inc finance lease, right-of-use asset, amortization for fiscal 2022 was $3.25M, a 5.55% increase from fiscal 2021.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.58M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $3.54M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $3.35M 10-K · filed 2026-02-25 | |||
| 2022-12-31 | $822.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.64M derived: sum of 2 quarters · filed 2025-02-18 | $2.45M derived: sum of 3 quarters · filed 2025-02-18 | $3.25M 10-K · filed 2025-02-18 |
| 2022-09-30 | $815.00K 10-Q · filed 2022-11-03 | $1.63M derived: sum of 2 quarters · filed 2022-11-03 | $2.43M 10-Q · filed 2022-11-03 | $3.23M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $810.00K 10-Q · filed 2022-08-05 | $1.62M 10-Q · filed 2022-08-05 | $2.41M derived: sum of 3 quarters · filed 2024-02-22 | $3.19M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $805.00K 10-Q · filed 2022-05-03 | $1.60M derived: sum of 2 quarters · filed 2024-02-22 | $2.38M derived: sum of 3 quarters · filed 2024-02-22 | $3.14M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.57M derived: sum of 2 quarters · filed 2024-02-22 | $2.33M derived: sum of 3 quarters · filed 2024-02-22 | $3.08M 10-K · filed 2024-02-22 |
| 2021-09-30 | $776.00K 10-Q · filed 2022-11-03 | $1.54M derived: sum of 2 quarters · filed 2022-11-03 | $2.28M 10-Q · filed 2022-11-03 | $3.02M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $760.00K 10-Q · filed 2022-08-05 | $1.51M 10-Q · filed 2022-08-05 | $2.24M derived: sum of 3 quarters · filed 2023-02-23 | $2.98M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $746.00K 10-Q · filed 2022-05-03 | $1.48M derived: sum of 2 quarters · filed 2023-02-23 | $2.22M derived: sum of 3 quarters · filed 2023-02-23 | $2.86M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $1.47M derived: sum of 2 quarters · filed 2023-02-23 | $2.12M derived: sum of 3 quarters · filed 2023-02-23 | $2.79M 10-K · filed 2023-02-23 |
| 2020-09-30 | $734.00K 10-Q · filed 2021-11-03 | $1.38M derived: sum of 2 quarters · filed 2021-11-03 | $2.05M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $645.00K 10-Q · filed 2020-08-03 | $1.32M 10-Q · filed 2020-08-03 | ||
| 2020-03-31 | $671.00K 10-Q · filed 2020-05-07 | |||
| 2019-12-31 | $284.00K 10-K · filed 2021-02-23 | |||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-03 | $0.00 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |